Abstract
1. We recently reported that the activation by UDP of rat P2Y6 nucleotide receptors expressed in 1321N1 astrocytoma cells protected them from TNFα-induced apoptosis by suppressing activation of caspase 3 and 8. This study aims to characterize the involvement of intracellular signaling pathways, including kinases, involved in the antiapoptotic effect of UDP.
2. Cell death was induced in 1321N1 astrocytoma cells permanently expressing the rat P2Y6 receptor by exposure to TNFα in the presence of cycloheximide. The apoptotic fraction was analyzed using flow cytometry.
3. The activation of P2Y6 receptors by UDP both protected the astrocytes from TNF-α induced apoptosis and activated protein kinase C (PKC) isotypes. The phorbol ester PMA also activated PKC and protected the cells from TNFα-induced cell death. The α- and ε-isotypes of PKC were both activated in a persistent fashion upon 5-min exposure to either UDP (10 μM) or the phorbol ester PMA (100 nM). The PKCζ isotype was markedly activated upon UDP treatment.
4. The addition of PKC inhibitors, GF109203X or Gö6976, partially antagonized the protective effect of UDP and reduced the UDP-induced phosphorylation of extracellular signal-regulated protein kinases (Erk). The inhibitors of Erk, PD98,059 or U0126, antagonized UDP-induced protection.
5. The antiapoptotic protein, Akt, was not affected by P2Y6 receptor activation. Incubation of the astrocytes with calcium modifiers, BAPTA-AM or dantrolene, did not affect the UDP-induced protection from apoptosis.
6. The addition of phospholipase C (PLC) inhibitors, D609 or U73122, partially antagonized both UDP-induced protection and PKC activation.
7. Therefore, it is suggested that P2Y6 receptors in 1321N1 cells, through coupling to PC-PLC and PI-PLC, activate PKC to protect against TNFα -induced apoptosis, in which the activation of Erk is involved in part.
Similar content being viewed by others
References
Aggarwal, B. B. (2000). Tumor necrosis factors receptor associated signaling molecules and their role in activation of apoptosis, JNK, and NF-κ B. Ann. Rheum. Dis. 59(Suppl. 1):i6-i16.
Chang, K., Hanaoka, K., Kumada, M., and Takuwa, Y. (1995). Molecular cloning and functional analysis of a novel P2 nucleotide receptor. J. Biol. Chem. 270:26152–26158.
Cheng, H.-L., and Feldman, E. L. (1998). Bidirectional regulation of p38 kinase and c-Jun N-terminal protein kinase by insulin-like growth factor-I. J. Biol. Chem. 273:14560–14565.
Communi, D., Parmentier, M., and Boeynaems, J. M. (1996). Cloning, functional expression and tissue distribution of the human P2Y6 receptor. Biochem. Biophys. Res. Commun. 222:303–308.
De Smaele, E., Zazzeroni, F., Papa, S., Nguyen, D. U., Jin, R., Jones, J., Cong, R., and Franzoso, G. (2001). Induction of gadd45beta by NF-kappaB downregulates pro-apoptotic JNK signalling. Nature 414:308–313.
Di, T., Sullivan, J. A., Magness, R. R., Zhang, L., and Bird, I. M. (2001). Pregnancy-specific enhancement of agonist-stimulated ERK-1/2 signaling in uterine artery endothelial cells increases Ca2+ sensitivity of endothelial nitric oxide synthase as well as cytosolic phospholipase A2. Endocrinology 142:3014–3026.
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., and Greenberg, M. E. (1997). Regulation of neuronal survival by the serine–threonine protein kinase Akt. Science 275:661–665.
Ekokoski, E., Webb, T. E., Simon, J., and Tornquist, K. (2001). Mechanisms of P2 receptor-evoked DNA synthesis in thyroid FRTL-5 cells. J. Cell. Physiol. 187:166–175.
Erlinge, D., Hou, M., Webb, T. E., Barnard, E. A., and Möller, S. (1998). Phenotype changes of the vascular smooth muscle cell regulate P2 receptor expression as measured by quantitative RT-PCR. Biochem. Biophys. Res. Commun. 248:864–870.
Gao, Z., Li, B. S., Day, Y. J., and Linden, J. (2001). A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol. Pharmacol. 59:76–82.
Gardner, A. M., and Johnson, G. L. (1996). Fibroblast growth factor-2 suppression of tumor necrosis factor α-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J. Biol. Chem. 271:14560–14566.
Gibson, E. M., Henson, E. S., Haney, N., Villanueva, J., and Gibson, S. B. (2002). Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release. Cancer Res. 62:488–496.
Harper, S., Webb, T. E., Charlton, S. J., Ng, L. L., and Boarder, M. R. (1998). Evidence that P2Y4 nucleotide receptors are involved in the regulation of rat aortic smooth muscle cells by UTP and ATP. Br. J. Pharmacol. 124:703–710.
Hatano, E., and Brenner, D. A. (2001). Akt protects mouse hepatocytes from TNF-alpha-and Fas-mediated apoptosis through NK-kappa B activation. Am. J. Physiol. Gastrointest. Liver Physiol. 281:G1357-G1368.
Higuchi, M., Singh, S., Chan, H., and Aggarwal, B. B. (1995). Protease inhibitors differentially regulate tumor necrosis factor-induced apoptosis, nuclear factor-kappa B activation, cytotoxicity, and differentiation. Blood 86:2248–2256.
Hou, M., Harden, T. K., Kuhn, C. M., Baldetorp, B., Lazarowski, E., Pendergast, W., Möller, T., Edvinsson, L., and Erlinge, D. (2002). UDP acts as a growth factor for vascular smooth muscle cells by activation of P2Y6 receptors. Am. J. Physiol. Heart Circ. Physiol. 282:H784-H792.
Huwiler, A., van Rossum, G., Wartmann, M., and Pfeilschifter, J. (1997). Stimulation by extracellular ATP and UTP of the stress-activated protein kinase cascade in rat renal mesangial cells. Br. J. Pharmacol. 120:807–812.
Ip, Y. T., and Davis, R. J. (1998). Signal transduction by the c-Jun N-terminal kinase (JNK)—From inflammation to development. Curr. Opin. Cell Biol. 10:205–219.
Javelaud, D., and Besancon, F. (2001). NF-kappa B activation results in rapid inactivation of JNK in TNFα-treated Ewing sarcoma cells: A mechanism for the anti-apoptotic effect of NF-kappa B. Oncogene 20:4365–4372.
Kim, S. G., Soltysiak, K. A., Gao, Z. G., Chang, T. S., Chung, E., and Jacobson, K. A. (2003). Tumor necrosis factor α-induced apoptosis in astrocytes is prevented by the activation of P2Y6, but not P2Y4 nucleotide receptors. Biochem. Pharmacol. 65:923–931.
King, B. F., Neary, J. T., Zhu, Q., Wang, S., Norenberg, M. D., and Burnstock, G. (1996). P2 purinoceptors in rat cortical astrocytes: Expression, calcium-imaging and signalling studies. Neuroscience 74:1187–1196.
Kulik, G., Klippel, A., and Weber, M. J. (1997). Antiapoptotic signalling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol. Cell. Biol. 17:1595–1606.
Kyriakis, J. M. (2001). Life-or-death decision. Nature 414:265–266.
Laouar, A., Glesne, D., and Huberman, E. (1999). Involvement of protein kinase C-β and ceramide in tumor necrosis factor α-induced but not Fas-induced apoptosis of human myeloid leukemia cells. J. Biol. Chem. 274:23526–23534.
Leirdal, M., and Sioud, M. (2000). Protein kinase Cα isotype regulates the activation of the MAP kinase ERK1/2 in human glioma cells: Involvement in cell survival and gene expression. Mol. Cell Biol. Res. Commun. 4:106–110.
Lenz, G., Gottfried, C., Luo, Z., Avruch, J., Rodnight, R., Nie, W. J., Kang, Y., and Neary, J. T. (2000). P(2Y) purinoceptor subtypes recruit different mek activators in astrocytes. Br. J. Pharmacol. 129:927–936.
Li, D., Yang, B., and Mehta, J. L. (1999). Tumor necrosis factor α enhances hypoxia-reoxygenation-mediated apoptosis in cultured human coronary artery endothelial cells: Critical role of protein kinase C. Cardiovasc. Res. 42:805–813.
Li, J., Zheng, R., Li, J., and Wang, Z. (2001). Mechanisms of the induction of apoptosis in human hepatoma cells by tumour necrosis factor-alpha. Cell Biol. Int. 25:1213–1219.
Malmsjö, M., Adner, M., Harden, T. K., Pendergast, W., Edvinsson, L., and Erlinge, D. (2000). The stable pyrimidines UDPβS and UTPγS discriminate between the P2 receptors that mediate vascular contraction and relaxation of the rat mesenteric artery. Br. J. Pharmacol. 131:51–56.
Marte, B. M., and Downward, J. (1997). PKB/Akt: Connecting phosphoinositide 3-kinase to cell survival and beyond. Trends Biochem. Sci. 22:355–358.
Martiny-Baron, G., Kazanietz, M. G., Mischak, H., Blumberg, P. M., Kochs, G., Hug, H., Marme, D., and Schachtele, C. (1993). Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 268:9194–9197.
Minden, A., and Karin, M. (1997). Regulation and function of the JNK subgroup of MAP kinases. Biochim. Biophys. Acta 1333:F85-F104.
Murga, C., Laguinge, L., Wetzker, R., Cuadrado, A., and Gutkind, J. S. (1998). Activation of Akt/protein kinase B by G protein-coupled receptors. A role for alpha and beta gamma subunits of heterotrimeric G proteins acting through phosphatidylinositol-3-OH kinasegamma. J. Biol. Chem. 273:19080–19085.
Neary, J. T., Zhu, Q., Kang, Y., and Dash, P. K. (1996a). Extracellular ATP induces formation of AP-1 complexes in astrocytes via P2 purinoceptors. Neuro report 7:2893–2896.
Neary, J. T., Rathbone, M. P., Cattabeni, F., Abbracchio, M. P., and Burnstock, G. (1996b). Trophic actions of extracellular nucleotides and nucleosides on glial and neuronal cells. Trends Neurosci. 19:13–18.
Neary, J. T. (1996). Trophic actions of extracellular ATP on astrocytes, synergistic interactions with fibroblast growth factors, and underlying signal transduction mechanisms. Ciba Found. Symp. 198:130–141.
Neary, J. T., Kang, Y., Bu, Y., Yu, E., Akong, K., and Peters, C. M. (1999). Mitogenic signaling by ATP/P2Y purinergic receptors in astrocytes: Involvement of a calcium-independent protein kinase C, extracellular signal-regulated protein kinase pathway distinct from the phosphatidylinositol-specific phospholipase C/calcium pathway. J. Neurosci. 19:4211–4220.
Neary, J. T., Lenz, G., Kang, Y., Rodnight, R., and Avruch, J. (2001). Role of mitogen-activated protein kinase cascades in P2Y receptor-mediated trophic activation of astroglial cells. Drug Dev. Res. 53:158–165.
Nicholas, R. A., Watt, W. C., Lazarowski, E. R., Li, Q., and Harden, T. K. (1996). Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: Identification of a UDP-selective, a UTP-selective, and an ATP-and UTP-specific receptor. Mol. Pharmacol. 50:224–229.
Nosaka, Y., Arai, A., Kanda, E., Akasaki, T., Sumimoto, H., Miyasaka, N., and Miura, O. (2001). Rac is activated by tumor necrosis factor α and is involved in activation of Erk. Biochem. Biophys. Res. Commun. 285:675–679.
Paul, A., Torrie, L. J., McLaren, G. J., Kennedy, C., Gould, G. W., and Plevin, R. (2000). P2Y receptor-mediated inhibition of tumor necrosis factor α-stimulated stress-activated protein kinase activity in EAhy926 endothelial cells. J. Biol. Chem. 275:13243–13249.
Post, G. R., Collins, L. R., Kennedy, E. D., Moskowitz, S. A., Aragay, A. M., Goldstein, D., and Brown, J. H. (1996). Coupling of the thrombin receptor to G12 may account for selective effects of thrombin on gene expression and DNA synthesis in 1321N1 astrocytoma cells. Mol. Biol. Cell 7:1679–1690.
Santiago-Perez, L. I., Flores, R. V., Santos-Berrios, C., Chorna, N. E., Krugh, B., Garrad, R. C., Erb, L., Weisman, G. A., and Gonzalez, F. A. (2001). P2Y2 nucleotide receptor signaling in human monocytic cells: Activation, desensitization, and coupling to mitogen-activated protein kinases. J. Cell. Physiol. 187:196–208.
Sautin, Y. Y., Crawford, J. M., and Svetlov, S. I. (2001). Enhancement of survival by LPA via Erk1/Erk2 and PI 3-kinase/Akt pathways in a murine hepatocyte cell line. Am. J. Physiol. Cell Physiol. 281:C2010-C2019.
Schulze-Osthoff, K., Ferrari, D., Los, M., Wesselborg, S., and Peter, M. E. (1998). Apoptosis signaling by death receptors. Eur. J. Biochem. 254:439–459.
Sellers, L. A., Simon, J., Lundahl, T. S., Cousens, D. J., Humphrey, P. P. A., and Barnard, E. A. (2001). Adenosine nucleotides acting at the human P2Y1 receptor stimulate mitogen-activated protein kinases and induce apoptosis. J. Biol. Chem. 276:16379–16390.
She, Q. B., Mukherjee, J. J., Chung, T., and Kiss, Z. (2000). Placental alkaline phosphatase, insulin, and adenine nucleotides or adenosine synergistically promote long-term survival of serum-starved mouse embryo and human fetus fibroblasts. Cell. Signal. 12:659–665.
Smith, L., Chen, L., Reyland, M. E., DeVries, T. A., Talanian, R. V., Omura, S., and Smith, J. B. (2000). Activation of atypical protein kinase C zeta by caspase processing and degradation by the ubiquitin-proteasome system. J. Biol. Chem. 275:40620–40627.
Strassheim, D., and Williams, C. L. (2000). P2Y2 purinergic and M3 muscarinic acetylcholine receptors activate different phospholipase C-beta isotypes that are uniquely susceptible to protein kinase C-dependent phosphorylation and inactivation. J. Biol. Chem. 275:39767–39772.
Takasuga, S., Katada, T., Ui, M., and Hazeki, O. (1999). Enhancement by adenosine of insulin-induced activation of phosphoinositide 3-kinase and protein kinase B in rat adipocytes. J. Biol. Chem. 274:19545–19550.
Tang, G., Minemoto, Y., Dibling, B., Purcell, N. H., Li, Z., Karin, M., and Lin, A. (2001). Inhibition of JNK activation through NF-kB target genes. Nature 414:313–317.
Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., and Loriolle, F. (1991). The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266:15771–15781.
Tran, S. E., Holmstrom, T. H., Ahonen, M., Kahari, V. M., and Eriksson, J. E. (2001). MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors. J. Biol. Chem. 276:16484–16490.
Tu, M. T., Luo, S. F., Wang, C. C., Chien, C. S., Chiu, C. T., Lin, C. C., and Yang, C. M. (2000). P2Y2 receptor-mediated proliferation of C6 glioma cells via activation of Ras/Raf/MEK/MAPK pathway. Br. J. Pharmacol. 129:1481–1489.
Woods, K. M., and Chapes, S. K. (1993). Three distinct cell phenotypes of induced-TNF cytotoxicity and their relationship to apoptosis. J. Leukoc. Biol. 53:37–44.
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., and Greenberg, M. E. (1995). Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis. Science 270:1326–1331.
Yagle, K., Lu, H., Guizzetti, M., Möller, T., and Costa, L. G. (2001). Activation of mitogen-activated protein kinase by muscarinic receptors in astroglial cells: Role in DNA synthesis and effect of ethanol. Glia 35:111–120.
Yazlovitskaya, E. M., Pelling, J. C., and Persons, D. L. (1999). Association of apoptosis with the inhibition of extracellular signal-regulated protein kinase activity in the tumor necrosis factor α-resistant ovarian carcinoma cell line UCI 101. Mol. Carcinog. 25:14–20.
Zhu, W., Zou, Y., Aikawa, R., Harada, K., Kudoh, S., Uozumi, H., Hayashi, D., Gu, Y., Yamazaki, T., Nagai, R., Yazaki, Y., and Komuro, I. (1999). MAPK superfamily plays an important role in daunomycin-induced apoptosis of cardiac myocytes. Circulation 100:2100–2107.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kim, S.G., Gao, ZG., Soltysiak, K.A. et al. P2Y6 Nucleotide Receptor Activates PKC to Protect 1321N1 Astrocytoma Cells Against Tumor Necrosis Factor-Induced Apoptosis. Cell Mol Neurobiol 23, 401–418 (2003). https://doi.org/10.1023/A:1023696806609
Issue Date:
DOI: https://doi.org/10.1023/A:1023696806609